Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$79.47 - $91.38 $1.06 Million - $1.22 Million
13,400 Added 12.47%
120,900 $10.7 Million
Q1 2023

May 10, 2023

BUY
$76.72 - $87.58 $8.13 Million - $9.28 Million
106,000 Added 7066.67%
107,500 $8.67 Million
Q3 2022

Nov 10, 2022

SELL
$80.75 - $95.31 $3.67 Million - $4.33 Million
-45,400 Reduced 96.8%
1,500 $121,000
Q2 2022

Aug 12, 2022

SELL
$87.4 - $113.09 $24.2 Million - $31.3 Million
-276,400 Reduced 85.49%
46,900 $4.21 Million
Q1 2022

Apr 13, 2022

BUY
$100.58 - $112.38 $19.6 Million - $21.9 Million
195,130 Added 152.24%
323,300 $35.9 Million
Q4 2021

Feb 11, 2022

BUY
$99.53 - $127.75 $12 Million - $15.4 Million
120,470 Added 1564.55%
128,170 $13.3 Million
Q2 2021

Aug 06, 2021

SELL
$118.19 - $131.5 $26.6 Million - $29.5 Million
-224,680 Reduced 96.69%
7,700 $956,000
Q1 2021

May 13, 2021

BUY
$111.18 - $119.74 $700,434 - $754,362
6,300 Added 2.79%
232,380 $27.5 Million
Q4 2020

Feb 08, 2021

BUY
$100.57 - $117.14 $400,268 - $466,217
3,980 Added 1.79%
226,080 $26.5 Million
Q3 2020

Nov 10, 2020

SELL
$90.13 - $108.78 $11.8 Million - $14.2 Million
-130,800 Reduced 37.06%
222,100 $23.1 Million
Q2 2020

Aug 12, 2020

SELL
$84.11 - $103.33 $958,854 - $1.18 Million
-11,400 Reduced 3.13%
352,900 $32.4 Million
Q1 2020

May 04, 2020

BUY
$72.92 - $121.3 $2.18 Million - $3.63 Million
29,958 Added 8.96%
364,300 $32.9 Million
Q4 2019

Jan 31, 2020

BUY
$104.49 - $114.54 $3.39 Million - $3.71 Million
32,400 Added 10.73%
334,342 $37.9 Million
Q3 2019

Oct 30, 2019

BUY
$98.02 - $111.18 $8 Million - $9.08 Million
81,642 Added 37.06%
301,942 $32.8 Million
Q2 2019

Aug 06, 2019

BUY
$84.15 - $99.38 $622,710 - $735,412
7,400 Added 3.48%
220,300 $21.5 Million
Q1 2019

May 08, 2019

BUY
$82.45 - $93.79 $17.6 Million - $20 Million
212,900 New
212,900 $19.4 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $115B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Payden & Rygel Portfolio

Follow Payden & Rygel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Payden & Rygel, based on Form 13F filings with the SEC.

News

Stay updated on Payden & Rygel with notifications on news.